Cliff Asness's CAPR Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 8,596 shares of Capricor Therapeutics, Inc. (CAPR) worth $248,081, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in CAPR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 12,361 shares. Largest reduction occurred in Q4 2024, reducing 28,519 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Capricor Therapeutics (CAPR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Capricor Therapeutics (CAPR) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -3,765 | Reduce 30.46% | 8,596 | $28.86 |
| Q3 2025 | +12,361 | New Buy | 12,361 | $7.21 |
| Q1 2025 | -11,097 | Sold Out | 0 | $0.00 |
| Q4 2024 | -28,519 | Reduce 71.99% | 11,097 | $13.80 |
| Q3 2024 | +39,616 | New Buy | 39,616 | $15.21 |
Cliff Asness's Capricor Therapeutics Investment FAQs
Cliff Asness first purchased Capricor Therapeutics, Inc. (CAPR) in Q3 2024, acquiring 39,616 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Capricor Therapeutics, Inc. (CAPR) for 5 quarters since Q3 2024.
Cliff Asness's largest addition to Capricor Therapeutics, Inc. (CAPR) was in Q3 2024, adding 39,616 shares worth $602,559.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 8,596 shares of Capricor Therapeutics, Inc. (CAPR), valued at approximately $248,081.
As of the Q4 2025 filing, Capricor Therapeutics, Inc. (CAPR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Capricor Therapeutics, Inc. (CAPR) was 39,616 shares, as reported at the end of Q3 2024.